“DCTs are here to stay, but they won’t replace all traditional clinical trials,” former FDA official says.
“If you don’t diversify, educate, and raise the level of understanding” in the clinical trial workforce, it “makes it that much harder to achieve” your overall diversity goals, expert says.
“Studies show CRCs spend about 25% of their time on data. Free them up from it, and they’ll have more time to enroll more patients and conduct more trials.”
“I’ve heard too much talk and not seen enough action.” Expert says it’s time to put muscle behind efforts to increase diversity in clinical research.